Home/Filings/4/0001104659-23-057156
4//SEC Filing

Raphael Erez 4

Accession 0001104659-23-057156

CIK 0001533998other

Filed

May 7, 8:00 PM ET

Accepted

May 8, 4:11 PM ET

Size

8.1 KB

Accession

0001104659-23-057156

Insider Transaction Report

Form 4
Period: 2023-05-04
Raphael Erez
DirectorChief Executive Officer
Transactions
  • Purchase

    Series B-2 Preferred Stock

    2023-05-04$1000.00/sh+30$30,00030 total
    Exercise: $3.37From: 2023-05-04Exp: 2026-05-04Common Stock
Holdings
  • Common Stock

    (indirect: By Dicilyon Consulting and Investment Ltd.)
    37,876
  • Common Stock

    1,112,059
Footnotes (3)
  • [F1]The amount shown represents the beneficial ownership of the issuer's securities held by Dicilyon Consulting and Investment Ltd. which may be deemed to be attributable to Mr. Raphael because Mr. Raphael possesses voting and dispositive power over the securities held by Dicilyon Consulting and Investment Ltd. by virtue of a proxy. Mr. Raphael disclaims beneficial ownership of the securities set forth herein.
  • [F2]The Series B Preferred Stock will automatically convert into shares of common stock, subject to certain beneficial ownership limitations, including a non-waivable 19.99% ownership blocker, on the 15-month anniversary of the issuance date.
  • [F3]The Series B Preferred Stock initially converts into shares of common stock at a conversion price of $3.37. In addition, the holders of Series B Preferred Stock will also be entitled dividends payable as follows: (i) a number of shares of Common Stock equal to five percent (5.0%) of the number of shares of Common Stock issuable upon conversion of the Series B Preferred Stock then held by such holder for each full quarter anniversary of holding for a total of four (4) quarters from the closing date, and (ii) a number of shares of common stock equal to ten percent (10%) of the number of shares of common stock issuable upon conversion of the Series B Preferred Stock then held by such holder on the fifth full quarter from the closing date.

Issuer

DarioHealth Corp.

CIK 0001533998

Entity typeother

Related Parties

1
  • filerCIK 0001668046

Filing Metadata

Form type
4
Filed
May 7, 8:00 PM ET
Accepted
May 8, 4:11 PM ET
Size
8.1 KB